Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Stoke Therapeutics, Inc. Filed Acc 0000895421-26-000321

Stakes reported in this filing

Reporting person Shares Of the class
Morgan Stanley 3,177,169 4.9%
Morgan Stanley Capital Services LLC 2,653,126 4.1%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…